Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model

In Vivo

Volumn 26, Issue 2, 2012, Pages 243-250

  Fotis, Lampros ^a   Agrogiannis, Georgios ^a   Vlachos, Ioannis S ^a   Pantopoulou, Alkistis ^a   Margoni, Angeliki ^a   Kostaki, Maria ^a   Verikokos, Christos ^a   Tzivras, Dimitrios ^a   Mikhailidis, Dimitri P ^b   Perrea, Despina ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; High density lipoprotein cholesterol; Intercellular adhesion molecule; Vasa vasorum; Vascular cell adhesion molecule

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; ENDOTHELIUM; FIBROBLAST; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASA VASORUM;

EID: 84857843889     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Price DT and Loscalzo J: Cellular adhesion molecules and atherogenesis. Am J Med 107(1): 85-97, 1999. (Pubitemid 29328286)
2. Galkina E and Ley K: Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27(11): 2292-301, 2007. (Pubitemid 350203942)
3. Aricescu AR and Jones EY: Immunoglobulin superfamily cell adhesion molecules: zippers and signals. Curr Opin Cell Biol 19(5): 543-550, 2007. (Pubitemid 350017878)
4. Guide for the Care and Use of Laboratory animals. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. 8th Edition. Washington (DC): National Academies Press (US), 2011.
5. Moghadasian MH: Experimental atherosclerosis: a historical overview. Life Sci 70(8): 855-865, 2002.
6. De Caterina R, Basta G, Lazzerini G, DeH'Omo G, Petrucci R, Morale M, Carmassi F and Pedrinelli R: Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vase Biol 17(11): 2646-2654, 1997. (Pubitemid 28016004)
7. Katsiki N, Athyros VG and Mikhailidis DP: New developments in the treatment and prevention of vascular disease, part 1. Curr Pharm Des 16(34): 3767-3769, 2010.
8. Hulthe J, Wikstrand J, Mattsson-Hulten L and Fagerberg B. Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Lond) 103(2): 123-129, 2002.
9. van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ, Hofman A and Witteman JC: Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol 22(5): 838-842, 2002. (Pubitemid 34517798)
10. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr. and Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96(12): 4219-4225, 1997. (Pubitemid 28007447)
11. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ and Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351(9096): 88-92, 1998. (Pubitemid 28026634)
12. de Lemos JA, Hennekens CH and Ridker PM: Plasma concentra-tion of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol 36(2): 423-426, 2000.
13. Ridker PM, Hennekens CH, Buring JE and Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12): 836-843, 2000. (Pubitemid 30165206)
14. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A and Haskard D. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358(9286): 971-976, 2001.
15. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, Elkhalil L, Fruchart JC and Ducimetiere P: Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 1770(1): 169-176, 2003. (Pubitemid 37083576)
16. Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M and Yusuf S: The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48(9): 1749-1755, 2005. (Pubitemid 41317828)
17. Keaney JF Jr., Massaro JM, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Sutherland P, Vita JA and Benjamin EJ: Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol 44(1): 168-173, 2004. (Pubitemid 38968477)
18. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D and Kyriakopoulos A: The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171(3): 223-229, 1993. (Pubitemid 23345967)
19. Wood KM, Cadogan MD, Ramshaw AL and Parums DV: The distribution of adhesion molecules in human atherosclerosis. Histopathology 22(5): 437-444, 1993. (Pubitemid 23168584)
20. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD and Fowkes FG: C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112(7): 976-983, 2005. (Pubitemid 41170265)
21. Blann AD, Seigneur M, Steiner M, Miller JP and McCollum CN: Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost 79(6): 1080-1085, 1998. (Pubitemid 28297150)
22. De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M, Carmassi F and Pedrinelli R: Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vase Biol 17(11): 2646-2654, 1997. (Pubitemid 28016004)
23. Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Alienberg J, Kubier W and Bode C: Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 17(3): 505-512, 1997. (Pubitemid 27133140)
24. Pradhan AD, Rifai N and Ridker PM: Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 106(7): 820-825, 2002.
25. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L and Meyer J: Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104(12): 1336-1342, 2001. (Pubitemid 32880144)
26. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine R, Bouter LM and Stehouwer CD: Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 49(3): 485-491, 2000. (Pubitemid 30131796)
27. Mulvihill NT, Foley JB, Murphy RT, Curtin R, Crean PA and Walsh M: Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart 85(6): 623-627, 2001. (Pubitemid 32973454)
28. Scalia R, Appel JZ 3rd and Lefer AM: Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol 18(7): 1093-1100, 1998. (Pubitemid 28323593)
29. Ulbrich H, Eriksson EE and Lindbom L: Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 24(12): 640-647, 2003. (Pubitemid 37494786)
30. Tardif JC: Antioxidants and atherosclerosis: emerging drug therapies. Curr Atheroscler Rep 7(1): 71-77, 2005.
31. Preiss DJ and Sattar N. Vascular cell adhesion molecule-1: A viable therapeutic target for atherosclerosis? Int J Clin Pract 61(4): 697-701, 2007. (Pubitemid 46449832)
32. Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL and Pfeffer MA: Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet 371(9626): 1761-8, 2008. (Pubitemid 351697951)
33. Hagemeyer CE, Ahrens I, Bassler N, Dschachutaschwili N and Chen YC, Eisenhardt SU, Bode C, Peter K: Genetic transfer of fusion proteins effectively inhibits VCAM-1-mediated cell adhesion and transmigration via inhibition of cytoskeletal anchorage. J Cell Mol Med 14(1-2): 290-302, 2010.